ArticleBMC cancer2022

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy.

Mingli Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.